Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hemp protein powder passes safety test in small study

NCT ID NCT07022275

Knowledge-focused Sponsor: National University of Natural Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a THC-free hemp protein powder is safe for healthy adults aged 18 to 65 who don't use cannabis. For 30 days, 32 volunteers took 40 grams of the supplement daily. Researchers checked for THC breakdown products in urine and monitored blood tests for liver, kidney, and overall health. The goal was to see if the supplement caused any side effects or lab abnormalities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Mar 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 to 65 years. * Able and willing to provide informed consent. * In good general health as determined by medical history and screening. * No cannabis or hemp product use within the past 90 days and willingness to avoid consuming other hemp-based or cannabinoid-containing products during the study period. * Willing to take 20 grams of hemp protein powder, twice a day, for 30 days, complete two blood draws, provide two urine samples, and fill out weekly surveys. Exclusion Criteria: * Positive THC-COOH baseline urine test. * Regular use of any medications that could interfere with THC metabolism. * History of substance abuse or dependence within the past year. * Individuals who are pregnant, lactating, or planning a pregnancy within the next 30 days. * Known allergy or hypersensitivity to cannabis, hemp, or any component of the study product. * Participants with chronic liver, kidney, or severe cardiovascular disease. * Participants with dietary restrictions that may prevent them from consuming the study product. * Current or recent participation in another research study within 14 days of screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Tolerability of hemp protein are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Tolerability of hemp protein

Contacts and locations

Locations

  • Helfgott Research Institute

    Portland, Oregon, 97202, United States